Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis

Food and Chemical Toxicology

Volumn 46, Issue 11, 2008, Pages 3375-3382

  Kim, Myung Hee ^a,b   Ryu, Shi Yong ^a   Bae, Myung Ae ^a   Choi, Joon Sig ^b   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Apoptosis; Baicalein; Bone resorption; MAP kinases; Osteoclast differentiation; Transcription factors

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BAICALEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; PROTEIN KINASE B; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS;

ACID PHOSPHATASE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; TRANSCRIPTION FACTORS;

MURINAE;

EID: 54449086557     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.08.016     Document Type: Article

References (49)

1. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., Morita I., Wagner E.F., Mak T.W., Serfling E., and Takayanagi H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202 (2005) 1261-1269
2. Bharti A.C., Takada Y., and Aggarwal B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-(B ligand-induced NF-(B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172 (2004) 5940-5947
3. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
4. Cano E., and Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20 (1995) 117-122
5. Chen C.J., Raung S.L., Liao S.L., and Chen S.Y. Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia. Biochem. Pharmacol. 5 (2004) 957-965
6. Chen Y.C., Chow J.M., Lin C.W., Wu C.Y., and Shen S.C. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol. Appl. Pharmacol. 216 (2006) 263-273
7. Eferl R., Hoebertz A., Schilling A.F., Rath M., Karreth F., Kenner L., Amling M., and Wagner E.F. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23 (2004) 2789-2799
8. Halleen J.M., Raisanen S., Salo J.J., Reddy S.V., Roodman G.D., Hentunen T.A., Lehenkari P.P., Kaija H., Vihko P., and Vaananen H.K. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 274 (1999) 22907-22910
9. Halleen J.M., Raisanen S.R., Alatalo S.L., and Vaananen H.K. Potential function for the ROS-generating activity of TRACP. J. Bone Miner. Res. 18 (2003) 1908-1911
10. Hong T., Jin G.B., Cho S., and Cyong J.C. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med. 68 (2002) 268-271
11. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., Timms E., Tan H.L., Elliott G., Kelley M.J., Sarosi I., Wang L., Xia X.Z., Elliott R., Chiu L., Black T., Scully S., Capparelli C., Morony S., Shimamoto G., Bass M.B., and Boyle W.J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96 (1999) 3540-3545
12. Hwang J.M., Tseng T.H., Tsai Y.Y., Lee H.J., Chou F.P., Wang C.J., and Chu C.Y. Protective effects of baicalein on tert-butyl hydroperoixde-induced hepatic toxicity in rat hepatocytes. J. Biomed. Sci. 12 (2005) 389-397
13. Igarashi Y., Lee M.Y., and Matsuzaki S. Acid phosphatases as markers of bone metabolism. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781 (2002) 345-358
14. Ikeda F., Nishimura R., Matsubara T., Hata K., Reddy S.V., and Yoneda T. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J. Immunol. 177 (2006) 2384-2390
15. Insogna K., Tanaka S., Neff L., Horne W., Levy J., and Baron R. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Mol. Reprod. Dev. 46 (1997) 104-108
16. Ishibashi O., Niwa S., Kadoyama K., and Inui T. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci. 79 (2006) 1657-1660
17. Johnson R.S., Spiegelman B.M., and Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71 (1992) 577-586
18. Kanno S., Hirano S., and Kayama F. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Toxicology 203 (2004) 211-220
19. Kim H.H., Kim J.H., Kwak H.B., Huang H., Han S.H., Ha H., Lee S.W., Woo E.R., and Lee Z.H. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem. Pharmacol. 67 (2004) 1647-1656
20. Kimata M., Shichijo M., Miura T., Serizawa I., Inagaki N., and Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy 30 (2000) 501-508
21. Lee B.H., Lee S.J., Kang T.H., Kim D.H., Sohn D.H., Ko G., and Kim Y.C. Baicalein, an in vitro antigenotoxic compound from Scutellaria baicalensis. Planta Med. 66 (2000) 70-71
22. Lee S.E., Woo K.M., Kim S.Y., Kim H.M., Kwack K., Lee Z.H., and Kim H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30 (2002) 71-77
23. Lee Z.H., and Kim H.H. Signal transduction by receptor activator of nuclear factor κB in osteoclasts. Biochem. Biophys. Res. Commun. 305 (2003) 211-214
24. -ΔΔCT method. Methods 25 (2001) 402-408
25. Lowe C., Yoneda T., Boyce B.F., Chen H., Mundy G.R., and Soriano P. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA 90 (1993) 4485-4489
26. Matsuo K., Owens J.M., Tonko M., Elliott C., Chambers T.J., and Wagner E.F. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24 (2000) 184-187
27. Matsuo K., Galson D.L., Zhao C., Peng L., Laplace C., Wang K.Z., Bachler M.A., Amano H., Aburatani H., Ishikawa H., and Wagner E.F. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279 (2004) 26475-26480
28. Miyazaki T., Katagiri H., Kanegae Y., Takayanagi H., Sawada Y., Yamamoto A., Pando M.P., Asano T., Verma I.M., Oda H., Nakamura K., and Tanaka S. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J. Cell Biol. 148 (2000) 333-342
29. Morabito N., Crisafulli A., Vergara C., Gaudio A., Lasco A., Frisina N., D'Anna R., Corrado F., Pizzoleo M.A., Cincotta M., Altavilla D., Ientile R., and Squadrito F. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res. 17 (2002) 1904-1912
30. Nakahata N., Tsuchiya C., Nakatani K., Ohizumi Y., and Ohkubo S. Baicalein inhibits Raf-1-mediated phosphorylation of MEK-1 in C6 rat glioma cells. Eur. J. Pharmacol. 461 (2003) 1-7
31. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., and Seiki M. Localization of matrix metalloproteinase 9 (92-kD gelatinase/type IV Collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72 (1995) 311-322
32. Ono K., and Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J. Biochem. 108 (1990) 609-613
33. Ozaki K., Kawata Y., Amano S., and Hanazawa S. Stimulatory effect of curcumin on osteoclast apoptosis. Biochem. Pharmacol. 59 (2000) 1577-1581
34. Parfitt A.M. Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. Clin. Obstet. Gynecol. 30 (1987) 789-811
35. Putnam S.E., Scutt A.M., Bicknell K., Priestley C.M., and Williamson E.M. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 21 (2007) 99-112
36. Rassi C.M., Lieberherr M., Chaumaz G., Pointillart A., and Cournot G. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J. Bone Miner. Res. 17 (2002) 630-638
37. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 27 (1999) 1229-1241
38. Rozen S., and Skaletsky H.J. Primer3 on the WWW for General Users and for Biologist Programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa 365-386
39. Shao Z.H., Hoek T.L., Qin Y., Becker L.B., Schumacker P.T., Li CQ., Dey L., Barth E., Halpern H., Rosen G.M., and Yuan C.S. Baicalein attenuates oxidant stress in cardiomyocytes. Am. J. Physiol. 282 (2002) H999-H1006
40. Soriano P., Montgomery C., Geske R., and Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64 (1991) 693-702
41. Stern P.H. Antiresorptive agents and osteoclast apoptosis. J. Cell Biochem. 101 (2007) 1087-1096
42. Sundaram K., Nishimura R., Senn J., Youssef R.F., London S.D., and Reddy S.V. RANK-ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res. 313 (2007) 168-178
43. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., and Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3 (2002) 889-901
44. Wagner E.F., and Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208 (2005) 126-140
45. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., and Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature 360 (1992) 741-745
46. Wattel A., Kamel S., Prouillet C., Petit J.P., Lorget F., Offord F., and Brazier M. J. Cell. Biochem. 92 (2004) 285-295
47. Wong B.R., Besser D., Kim N., Arron J.R., Vologodskaia M., Hanafusa H., and Choi Y. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4 (1999) 1041-1049
48. Woo J.T., Nakagawa H., Notoya M., Yonezawa T., Udagawa N., Lee I.S., Ohnishi M., Hagiwara H., and Nagai K. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol. Pharm. Bull. 27 (2004) 504-509
49. Yamagishi T., Otsuka E., and Hagiwara H. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142 (2001) 3632-3637